LATEST NEWS AND ARTICLES
From events, scientific articles to PR, you will find here all our latest news.
- News
Poietis contributes to shaping the future standards of 3D bioprinting
On October 21, our founder Fabien Guillemot will take part in the European Commission’s Joint Research Centre workshop in Brussels:
🧬 “3D Bioprinting: Towards Standards in Biomedicine”
- News
Poietis Joins the 2025 Biofabrication International Conference
We were delighted to take part in this year’s International Conference on Biofabrication, where we showcased our Next-Generation Bioprinting (NGB) platform through live demos!
- News
7th TERMIS World Congress 2024
7th TERMIS World Congress in Seattle, USA, to discuss the latest advancements in tissue engineering and regenerative medicine !
- Press release
HVD Life Science and Poietis announce a distribution partnership for Poietis’ NGB-R platform
Poietis and HVD Life Sciences are pleased to announce the signature of their collaboration for the distribution of Poietis’ Next-Generation Bioprinting (NGB) platform designed for translational research in Austria and Germany.
- News
👩🏻🔬 Revolutionizing Organ-on-Chip Models with Next-Generation Bioprinting
Poietis's NGB platform, offers unparalleled precision in 3D bioprinting, addressing key challenges in organ-on-chip (OoC) development.
- News
🧠 Poietis Partners in the Groundbreaking 4-DBR Project
We are proud to be partner in the 4-Deep Brain Reconstruction (4-DBR) initiative, a Horizon European Innovation Council (EIC) Pathfinder Open project aimed at revolutionizing the treatment of neurodegenerative disorders.
- News
🔬 Exciting Times in Stem Cell Research! 🧠
The French Society for Stem Cell Research (@FSSCR) recently concluded a three-day conference, drawing over 300 participants deeply engaged in the latest stem cell research developments.
- Press release
Poietis and Assistance Publique – Hôpitaux de Marseille (AP-HM) announce the first installation of a 3D bioprinting platform for manufacturing implantable biological tissues in hospitals
The installation of the NGB (Next-Generation Bioprinting) robotic bioprinting platform developed by Poietis in the Advanced Therapy Medicinal Product (ATMP) manufacturing area of the Hôpital de la Conception represents a world premiere and opens up very promising perspectives in regenerative medicine. The objective is now to start the first clinical trial of a 3D printed human tissue.
- Press release
Poietis announces formation of Scientific Advisory Board and appoints two first prominent Regenerative Medicine experts
Poietis, 4D Bioprinting company, announces formation of Scientific Advisory Board (SAB) and appointment of two first prominent Scientists in Regenerative Medicine: Dr. Gurtner and Dr. May
- Press release
Poietis signs a clinical research collaboration contract with the Assistance Publique – Hôpitaux de Marseille (AP-HM)
Poietis, leading bioprinting company, and the « Assistance Publique – Hôpitaux de Marseille » (AP-HM) announced today that they have entered into a partnership through the signature the 20th of January of a clinical research collaboration contract on a bioprinted tissue engineering product.
Do you want to know more about NGB platform?